R
Repligen CorpRGEN
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are 'inspiring advances in bioprocessing' for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and.
US StocksBiotechnologyHealthcareMid CapGrowth Stocks
RGEN 가격 추세
Repligen Corp · TradingView 전체 차트
NASDAQ:RGEN